newsfilter
← Latest News
GlobeNewswire·

GBT Reports First Quarter 2022 Financial Results

Achieved Oxbryta® (voxelotor) net revenues of $55.2 million in the first quarter 2022, a 41% increase year over year Strong new prescription growth driven by the recent launch for children ages 4 to less than 12 years and improving trends for patie